Charles Gold
NPI 1073584330 · Optometrist · New York, NY
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Charles Gold is a Optometrist provider in New York, NY (NPI 1073584330).
Provider details
- NPI number
- 1073584330
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Sex
- Male
- Sole proprietor
- Yes
- License
- 4232 (NY)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
162 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| 2d Ultrasound Scan of Eye Tissue and Structures76512 | 28 | $49 |
| Photography of the Retina92250 | 23 | $38 |
| Photography of Content of Eyes92285 | 23 | $24 |
| Ultrasound Scan of Cornea to Determine Thickness76514 | 17 | $12 |
| Exam of the Internal Drainage System of Eye92020 | 17 | $30 |
| Exam of Visual Field With Extended Testing92083 | 16 | $71 |
| Established Patient Complete Exam of Visual System92014 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 27 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Lifitegrastbrand: Xiidra | 2,138 | 465 |
| Varenicline Tartratebrand: Tyrvaya | 1,107 | 293 |
| Bromfenac Sodiumbrand: Prolensa | 500 | 177 |
| Cyclosporinebrand: Restasis | 429 | 88 |
| Bromfenac Sodium | 335 | 130 |
| Bimatoprostbrand: Lumigan | 279 | 71 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$744 across 34 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-26
- Last updated
- 2013-02-04
Frequently asked questions
- What is Charles Gold's NPI number?
- Charles Gold's National Provider Identifier (NPI) is 1073584330, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Charles Gold's specialty?
- Charles Gold is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
- Where is Charles Gold located?
- Charles Gold's practice location on file with NPPES is 4047 Broadway, New York, NY 10032-1516.
- What is Charles Gold's phone number?
- The practice phone number listed in the NPPES registry for Charles Gold is (212) 927-2020.
- Does Charles Gold accept Medicare?
- Charles Gold is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Charles Gold's NPI active?
- Yes — Charles Gold's NPI (1073584330) is active in the NPPES registry as of the last update on 2013-02-04.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.